Aclaris Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Aclaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aclaris Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aclaris Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $119k | 114k | 1.05 |
| 2023-09-30 | $778k | 114k | 6.85 |
| 2023-06-30 | $712k | 88k | 8.09 |
| 2023-03-31 | $712k | 88k | 8.09 |
| 2022-12-31 | $1.4M | 88k | 15.75 |
| 2022-09-30 | $1.4M | 87k | 15.74 |
| 2022-06-30 | $1.2M | 86k | 13.96 |
| 2022-03-31 | $851k | 49k | 17.24 |
| 2021-12-31 | $718k | 49k | 14.54 |
| 2021-09-30 | $656k | 37k | 18.00 |
| 2021-06-30 | $549k | 31k | 17.56 |
| 2019-03-31 | $68k | 11k | 5.99 |
| 2017-12-31 | $236k | 9.6k | 24.66 |
| 2017-09-30 | $6.0M | 234k | 25.81 |
| 2017-06-30 | $3.0M | 110k | 27.12 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas